全文获取类型
收费全文 | 12518篇 |
免费 | 1227篇 |
国内免费 | 261篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 252篇 |
妇产科学 | 164篇 |
基础医学 | 549篇 |
口腔科学 | 85篇 |
临床医学 | 1316篇 |
内科学 | 1797篇 |
皮肤病学 | 202篇 |
神经病学 | 780篇 |
特种医学 | 298篇 |
外国民族医学 | 1篇 |
外科学 | 592篇 |
综合类 | 1408篇 |
现状与发展 | 1篇 |
预防医学 | 1683篇 |
眼科学 | 93篇 |
药学 | 3785篇 |
6篇 | |
中国医学 | 430篇 |
肿瘤学 | 516篇 |
出版年
2024年 | 21篇 |
2023年 | 412篇 |
2022年 | 657篇 |
2021年 | 923篇 |
2020年 | 827篇 |
2019年 | 726篇 |
2018年 | 681篇 |
2017年 | 579篇 |
2016年 | 564篇 |
2015年 | 559篇 |
2014年 | 1182篇 |
2013年 | 1059篇 |
2012年 | 925篇 |
2011年 | 967篇 |
2010年 | 731篇 |
2009年 | 573篇 |
2008年 | 528篇 |
2007年 | 441篇 |
2006年 | 323篇 |
2005年 | 280篇 |
2004年 | 189篇 |
2003年 | 162篇 |
2002年 | 116篇 |
2001年 | 85篇 |
2000年 | 69篇 |
1999年 | 65篇 |
1998年 | 46篇 |
1997年 | 48篇 |
1996年 | 32篇 |
1995年 | 42篇 |
1994年 | 26篇 |
1993年 | 29篇 |
1992年 | 24篇 |
1991年 | 11篇 |
1990年 | 14篇 |
1989年 | 17篇 |
1988年 | 10篇 |
1987年 | 6篇 |
1986年 | 15篇 |
1985年 | 12篇 |
1984年 | 13篇 |
1983年 | 3篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 3篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 726 毫秒
91.
92.
93.
目的:观察纤维支气管镜灌洗联合常规药物治疗变应性支气管肺曲霉病(ABPA)患者的效果。方法:选取94例ABPA患者作为研究对象,按照随机数字表法分为观察组和对照组各47例。对照组采取常规药物治疗,观察组在对照组的基础上联合纤维支气管镜灌洗治疗。比较两组临床疗效和不良反应发生率。结果:观察组治疗总有效率为89.36%(42/47),明显高于对照组的72.34%(34/47),差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:纤维支气管镜灌洗联合常规药物治疗ABPA患者的效果优于单纯常规药物治疗,且安全性好。 相似文献
94.
《Vaccine》2021,39(11):1642-1651
Adult pertussis vaccination is increasingly recommended to control pertussis in the community. However, there is little data on the duration and kinetics of immunity to pertussis boosters in adults. We compared IgG responses to vaccination with a tetanus, low-dose diphtheria, low-dose acellular pertussis (Tdap) booster at 1 week, 1 month and 1 year post-vaccination in whole-cell (wP)-primed Australian paediatric healthcare workers who had received an adult Tdap booster 5–12 years previously, to those who received their first Tdap booster.Tdap vaccination was well tolerated in both groups. Previously boosted adults had significantly higher pre-vaccination IgG concentrations for all vaccine-antigens, and more were seropositive for pertussis toxin (PT)-specific IgG (≥ 5 IU/mL) (69.5%; 95% confidence interval (CI) 59.5–79.5) than adults in the naïve group (45.2%; 95% CI 32.8-57.5). Tdap vaccination significantly increased IgG responses 1 month post-vaccination in both groups. This increase was more rapid in previously boosted than in naïve adults, with geometric mean fold-increases in PT-IgG at 1 week post vaccination of 3.6 (95% CI 2.9–4.3) and 2.6 (95% CI 2.2–3.2), respectively. Antibody waning between 1 month and 1 year post-vaccination was similar between groups for IgG specific to PT and filamentous haemagglutinin (FHA), but was faster for IgG against pertactin (PRN) in the naïve group (GMC ratio 0.36; 95% CI 0.31–0.42) than the previously boosted group (GMC ratio 0.45; 95% CI 0.39–0.50). At baseline, all but one adult had protective IgG titres against tetanus toxin (TT) (≥ 0.1 IU/mL), and 75.6% in the previously boosted and 61.3% in the naïve group had protective IgG titres against diphtheria toxoid (DT) of ≥ 0.1 IU/mL.This study shows that pertussis immune memory is maintained up to 12 years after Tdap vaccination in wP-primed Australian adults. There was no evidence that pertussis immune responses waned faster after a booster dose. These findings support current recommendations of repeating Tdap booster vaccination in paediatric healthcare workers at least every 10 years. Clinical trials registry: ACTRN12615001262594. 相似文献
95.
96.
《Health policy (Amsterdam, Netherlands)》2020,124(8):888-894
At the beginning of their career, civil servants in Germany can choose between the social health insurance (SHI) system and a private plan combined with a direct reimbursement of the government of up to 70 percent. Most civil servants chose the latter, not only but also because they have to cover all contributions in the social system themselves, while regular employees get nearly 50 percent from their employers. The city state of Hamburg decided to change the system by paying half of the contributions if civil servants choose the social plan. We use a stochastic microsimulation model to analyse which socio-economic types of civil servants could benefit from the Hamburg plan and if this changes the mix of insured persons in the SHI system. Our results show that low income and high morbidity types as well as families have a substantially higher incentive to choose SHI. This reform might thereby increase the adverse selection of high risk cases towards SHI. 相似文献
97.
目的分析调强放射治疗(IMRT)联合TP方案治疗晚期食管鳞癌的临床疗效及对患者血清基质金属蛋白酶2(MMP2)、组织金属蛋白酶抑制剂2(TIMP2)、nm23-H1及不良反应的影响。方法选取晚期食管鳞癌患者80例为研究对象,按随机数字表法将其分为观察组(n=40,采用IMRT联合TP方案化疗)、对照组(n=40,单纯采用IMRT治疗),比较2组临床疗效、治疗前后血清MMP2、TIMP2、nm23-H1表达阳性率、局控率与生存情况及不良反应。结果观察组治疗有效率(85.00%)明显高于对照组(65.00%)(P<0.05)。治疗后2组血清MMP2表达阳性率下降,而TIMP2、nm23-H1表达阳性率上升,且观察组治疗后血清MMP2表达阳性率低于对照组,而TIMP2、nm23-H1表达阳性率高于对照组(P<0.05)。观察组治疗后1年、2年局控率高于对照组,但2组治疗后1年、2年生存率差异无统计学意义(P>0.05)。观察组白细胞减少、放射性食管炎发生率高于对照组(P<0.05),2组其他不良反应发生率差异无统计学意义(P>0.05)。结论晚期食管癌患者采用IMRT联合TP方案治疗可获得较好的疗效,对患者血清MMP2、TIMP2、nm23-H1有明显改善,但可能会较单纯IMRT治疗具有更多不良反应,需加以监测。 相似文献
98.
99.
100.
Tsubasa Hiraki Miho Hatanaka Akiko Arimura Hisao Kawahira Mari Kirishima Ikumi Kitazono Michiko Horinouchi Michiyo Higashi Takuro Kanekura Akihide Tanimoto 《Journal of cutaneous pathology》2020,47(2):154-160
Nivolumab and pembrolizumab are humanized IgG4 monoclonal antibodies against programmed cell death 1 (PD-1). Although these agents are effective in treating advanced melanoma, non-small-cell lung carcinoma, and other types of cancers, various adverse events have been reported. Cutaneous adverse events are particularly prevalent and, while granulomatous/sarcoid-like reactions are uncommon, they are increasingly recognized as immune-related adverse events associated with immune checkpoint inhibitors. Herein, we report two cases of granulomatous/sarcoid-like reaction with foreign material, mimicking metastatic malignancy after PD-1 inhibitor treatment. Clinicians should be aware of the existence of cutaneous lesions and perform biopsy if needed to prevent misdiagnosis and unnecessary adjustments to immunotherapy. 相似文献